ARDS market seen reaching $2.42 billion by 2030

The acute respiratory distress syndrome market is forecast to grow from $1.41 billion in 2025 to $2.42 billion by 2030, driven by rising respiratory illness, ICU expansion and advances in ventilation and ECMO. North America held the largest market share in 2025, according to The Business Research Company.

Why it matters: - Acute respiratory distress syndrome is a life-threatening lung condition that often affects critically ill patients. - Rising cases of respiratory disease are increasing demand for ICU care, ventilation support and ARDS therapies. - The market forecast points to sustained growth in critical care tools and treatment capacity.

What happened: - The Business Research Company released its Respiratory Distress Syndrome Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Oct. 29, 2026. - The report estimates the ARDS market will rise from $1.41 billion in 2025 to $1.56 billion in 2026. - The report projects the market will reach $2.42 billion by 2030. - The company also cites a 10.5% CAGR for 2025-2026 and an 11.7% CAGR for the longer-term forecast period.

The details: - ARDS is described as a condition marked by stiff lungs, reduced blood oxygen levels and widespread inflammatory lung injury. - Standard treatment relies on mechanical ventilation with low tidal volumes and positive end-expiratory pressure, or PEEP, to improve oxygen delivery while limiting further lung damage. - Recent growth has been supported by more respiratory infections, better hospital ICU infrastructure, wider awareness of ARDS management protocols, limited access to advanced ventilation systems and greater use of supportive care. - Future growth is expected to be supported by advances in mechanical ventilation and extracorporeal membrane oxygenation, or ECMO, devices. - The report also points to more R&D in ARDS therapeutics, expansion of critical care units, higher investment in personalized patient management and more cases of severe pneumonia and sepsis. - Key trends include broader use of mechanical ventilation and ECMO, higher ARDS prevalence tied to COVID-19 and other respiratory illnesses, better diagnostic testing for early detection and continued buildout of ICU facilities focused on tailored supportive therapies. - The report says North America held the largest ARDS market share in 2025. - Other regions covered include Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook reflects a broader shift toward more intensive and specialized respiratory care. - The long-term forecast suggests hospitals and device makers may keep investing in ICU capacity, advanced ventilation and earlier diagnosis. - The persistence of respiratory illness remains a core demand driver, not a one-off pandemic effect.

What's next: - The report says the market will continue expanding through 2030 as treatment technology and critical care infrastructure improve. - The Business Research Company is offering a free sample of the report and a full version through its website. - The company also lists report add-ons including TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated trend graphics. - More information is available in the full report and the free sample.

The bottom line: - ARDS is becoming a bigger global critical-care market, with demand rising alongside respiratory illness and ICU treatment needs.